GB9908190D0 - Diagnosis of lysosomal storage disorders using saposins and other markers - Google Patents

Diagnosis of lysosomal storage disorders using saposins and other markers

Info

Publication number
GB9908190D0
GB9908190D0 GBGB9908190.3A GB9908190A GB9908190D0 GB 9908190 D0 GB9908190 D0 GB 9908190D0 GB 9908190 A GB9908190 A GB 9908190A GB 9908190 D0 GB9908190 D0 GB 9908190D0
Authority
GB
United Kingdom
Prior art keywords
saposins
markers
diagnosis
lysosomal storage
storage disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9908190.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharming Intellectual Property BV
Original Assignee
Pharming Intellectual Property BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharming Intellectual Property BV filed Critical Pharming Intellectual Property BV
Priority to GBGB9908190.3A priority Critical patent/GB9908190D0/en
Publication of GB9908190D0 publication Critical patent/GB9908190D0/en
Priority to AT00908836T priority patent/ATE424562T1/en
Priority to KR1020017011737A priority patent/KR20020021775A/en
Priority to EP00908836A priority patent/EP1163527B1/en
Priority to IL14534500A priority patent/IL145345A0/en
Priority to KR1020087024543A priority patent/KR20080102423A/en
Priority to CA002366232A priority patent/CA2366232C/en
Priority to PCT/AU2000/000193 priority patent/WO2000055632A1/en
Priority to DE60041694T priority patent/DE60041694D1/en
Priority to NZ514166A priority patent/NZ514166A/en
Priority to AU31357/00A priority patent/AU776842B2/en
Priority to US09/936,957 priority patent/US7378231B1/en
Priority to JP2000605213A priority patent/JP4703008B2/en
Priority to IL145345A priority patent/IL145345A/en
Priority to NZ533214A priority patent/NZ533214A/en
Priority to US10/973,189 priority patent/US7361481B2/en
Priority to JP2010049695A priority patent/JP2010139511A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB9908190.3A 1999-03-17 1999-04-09 Diagnosis of lysosomal storage disorders using saposins and other markers Ceased GB9908190D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB9908190.3A GB9908190D0 (en) 1999-04-09 1999-04-09 Diagnosis of lysosomal storage disorders using saposins and other markers
JP2000605213A JP4703008B2 (en) 1999-03-17 2000-03-17 Use of at least one saposin level for diagnosing or monitoring lysosomal storage disorders in a subject
DE60041694T DE60041694D1 (en) 1999-03-17 2000-03-17 NOW USE OF SAPOSINS AND OTHER MARKERS
AU31357/00A AU776842B2 (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
EP00908836A EP1163527B1 (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
IL14534500A IL145345A0 (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
KR1020087024543A KR20080102423A (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
CA002366232A CA2366232C (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
PCT/AU2000/000193 WO2000055632A1 (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
AT00908836T ATE424562T1 (en) 1999-03-17 2000-03-17 DIAGNOSIS OF LYSOSOMAL STORAGE DISEASES USING SAPOSINS AND OTHER MARKERS
NZ514166A NZ514166A (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
KR1020017011737A KR20020021775A (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
US09/936,957 US7378231B1 (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
IL145345A IL145345A (en) 1999-03-17 2001-09-10 Diagnosis of lysosomal storage disorders using saposins and other markers
NZ533214A NZ533214A (en) 1999-03-17 2004-05-28 Diagnosis of lysosomal storage disorders using saposins and other markers
US10/973,189 US7361481B2 (en) 1999-04-09 2004-10-26 Diagnosis of lysosomal storage disorders using saposins and other markers
JP2010049695A JP2010139511A (en) 1999-03-17 2010-03-05 Diagnosis of lysosomal storage disorders using saposin and other marker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9908190.3A GB9908190D0 (en) 1999-04-09 1999-04-09 Diagnosis of lysosomal storage disorders using saposins and other markers

Publications (1)

Publication Number Publication Date
GB9908190D0 true GB9908190D0 (en) 1999-06-02

Family

ID=10851273

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9908190.3A Ceased GB9908190D0 (en) 1999-03-17 1999-04-09 Diagnosis of lysosomal storage disorders using saposins and other markers

Country Status (2)

Country Link
JP (1) JP4703008B2 (en)
GB (1) GB9908190D0 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020021775A (en) * 1999-03-17 2002-03-22 위민즈 앤드 칠드런즈호스피틀 Diagnosis of lysosomal storage disorders using saposins and other markers
JP4833831B2 (en) * 2003-03-31 2011-12-07 ウイミンズ、アンド、チルドランズ、ホスピトル Multiple screening for lysosomal storage diseases (LDS)
ES2731920T3 (en) * 2013-05-14 2019-11-19 Centogene Ag Method for the diagnosis of Niemann-Pick disease

Also Published As

Publication number Publication date
JP2002539455A (en) 2002-11-19
JP4703008B2 (en) 2011-06-15

Similar Documents

Publication Publication Date Title
MXPA02004770A (en) Therapeutic compositions and methods of use thereof.
HUP0101854A3 (en) The use of fumaric acid derivatives in transplant medicine
IL144954A0 (en) Quinazolines and therapeutic use thereof
HK1043613A1 (en) Microfibers and method of making
HK1041697A1 (en) Benzoheterocycles and their use as mek inhibitors
IL148657A0 (en) Stent range transducers and methods of use
HUP0200548A2 (en) Pharmaceutical compositions and their use
IL141403A0 (en) Deleted adenoviruses and methods of making and administering the same
AU7375100A (en) Water absorbent keratin and gel formed therefrom
HUP0200386A2 (en) Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity and pharmaceutical compositions containing them and their use
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
HUP0004886A3 (en) Withrawer and tearing mechanizm and harvester
EP1183030A4 (en) Methods of making and using n-desmethylzopiclone
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
FR2791747B1 (en) COUPLING DISC
AU4848200A (en) Intravascular device and methods of manufacture and use
GB2367103B (en) Connector and method of use of the connector
EG22491A (en) Rest-breaking composition and use thereof
HK1041200A1 (en) Cyclopentanone derivatives and their use
GB9907965D0 (en) Medical use
GB9908190D0 (en) Diagnosis of lysosomal storage disorders using saposins and other markers
PL363048A1 (en) Azabicyclic derivatives and their therapeutic use
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
FR2789137B1 (en) COUPLING DISC

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)